A Study of 2-Iminobiotin in Neonates With Perinatal Asphyxia

PHASE2TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

October 31, 2014

Study Completion Date

March 31, 2016

Conditions
Perinatal Asphyxia
Interventions
DRUG

2-Iminobiotin

2-Iminobiotin is formulated as a 0.75 mg/ml isotonic, iso-osmotic, saline solution with a pH of 4. It is administered as a solution for I.V.infusion through a central catheter. Six pulse doses will be given in 20 hours. Dosage will starts with 0.2 mg/kg/dose, but may be adapted during the study.

Trial Locations (2)

35540

T.R. Ministry of Health Izmir Tepecik Training and Research Hospital, Izmir

65080

Yıl University Medical Faculty Hospital, Van

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Neurophyxia B.V.

INDUSTRY

NCT01626924 - A Study of 2-Iminobiotin in Neonates With Perinatal Asphyxia | Biotech Hunter | Biotech Hunter